An FDA application for TAR-200 to treat BCG-unresponsive high-risk non-muscle-invasive bladder cancer is under real-time ...

The ghosts of skewed expenditure on vaccines by the Ministry of Health during the Covid-19 pandemic, the issuance of fake ...

However, Kenya Medical Supplies Agency (Kemsa) CEO Waqo Erjesa said on Wednesday they have sufficient stocks of the HIV ...

This lies against a backdrop of a nationwide shortage of BCG vaccines, as reports indicated that it has been out of stock for ...

Through the Kenya Medical Supplies Authority (KEMSA) Chief Executive Officer Waqo Erjesa, the government confirmed that there ...